{"id":20415,"date":"2021-08-18T12:13:56","date_gmt":"2021-08-18T10:13:56","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=20415"},"modified":"2021-08-18T12:13:56","modified_gmt":"2021-08-18T10:13:56","slug":"nvsc-kviecia-dalyvauti-tyrime-tai-gali-suteikti-gyvybiskai-butinu-ziniu-apie-covid-19-3","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/en\/2021\/08\/18\/nvsc-kviecia-dalyvauti-tyrime-tai-gali-suteikti-gyvybiskai-butinu-ziniu-apie-covid-19-3\/","title":{"rendered":"NVSC kvie\u010dia dalyvauti tyrime: tai gali suteikti gyvybi\u0161kai b\u016btin\u0173 \u017eini\u0173 apie COVID-19"},"content":{"rendered":"

Lietuvos mokslininkai, tirdami COVID-19 liga sirgusi\u0173 ar s\u0105lyt\u012f su sergan\u010diaisiais tur\u0117jusi\u0173, ta\u010diau neu\u017esikr\u0117tusi\u0173 \u017emoni\u0173 genus, siekia nauj\u0173 \u017eini\u0173 apie koronavirus\u0105. Taip tikimasi nustatyti tuos genus, kurie apsaugo nuo COVID-19 infekcijos arba, prie\u0161ingai \u2013 lemia sunki\u0105 lig\u0105.<\/strong><\/p>\n

Pla\u010diau apie tyrim\u0105<\/strong><\/a><\/h3>\n

Vertinama, kad \u0161io tyrimo metu gauta informacija pad\u0117s sukurti veiksming\u0105 gydym\u0105, leis nusp\u0117ti, kokio sunkumo liga sirgs u\u017esikr\u0117t\u0119s asmuo ir kokio gydymo tokiam ligoniui prireiks, taip pat \u2013 nusp\u0117ti viruso plitim\u0105 ir tokiu b\u016bdu sustabdyti infekcij\u0105 iki jai i\u0161plintant didel\u0117je teritorijoje.<\/p>\n

Pasak Nacionalinio visuomen\u0117s sveikatos centro (NVSC) Vilniaus departamento, kuris taip pat prisideda prie \u0161io tyrimo, direktor\u0117s Rolandos Lingien\u0117s, siekiant pl\u0117sti \u017einias apie koronavirusin\u0119 infekcij\u0105, itin reik\u0161mingas tampa t\u0173 \u017emoni\u0173, kurie su infekcija susid\u016br\u0117, ind\u0117lis.<\/p>\n

\u201eKvie\u010diame tyrime dalyvauti visus, kurie persirgo COVID-19 liga, taip pat tuos, kurie tur\u0117jo didel\u0117s rizikos s\u0105lyt\u012f, bet nesusirgo. Taip itin paprastai galite prisid\u0117ti prie dideli\u0173 mokslo laim\u0117jim\u0173. Kai kam tai gali reik\u0161ti \u0161ans\u0105 gyventi, tad ta valanda gydymo \u012fstaigoje ir viso labo keturi m\u0117gintuv\u0117liai kraujo yra tai, k\u0105 d\u0117l itin svarbi\u0173 tiksl\u0173, neabejoju, galima padaryti\u201c, \u2013 sako R. Lingien\u0117.<\/p>\n

Numatyta, kad biomedicininiame tyrime dalyvausian\u010diam \u017emogui reik\u0117s atlikti itin paprastas proced\u016bras \u2013 pasira\u0161yti informuoto asmens sutikimo form\u0105, u\u017epildyti klausimyn\u0105 apie sveikat\u0105, tuomet i\u0161 venos asmeniui bus paimami keturi kraujo m\u0117gintuv\u0117liai. Visos \u0161ios proced\u016bros u\u017etruks ma\u017eiau nei valand\u0105.<\/p>\n

\u017dmogus tur\u0117s atvykti \u012f Vilniaus universiteto ligonin\u0117s Santaros klinik\u0173 Infekcini\u0173 lig\u0173 centr\u0105 (tel.: +3705 275 2594, Santari\u0161ki\u0173 g. 14, Vilnius) tyrimo proced\u016broms.<\/p>\n

Biomedicinin\u012f tyrim\u0105 vykdo Vilniaus universitetas ir VUL Santaros klinikos bendradarbiaujant su Suomijos Molekulin\u0117s medicinos institutu dalyvaudami tarptautin\u0117je iniciatyvoje \u201eCOVID-19 Host Genetics Initiative\u201c.<\/p>\n

\u012e biomedicinin\u012f tyrim\u0105 kvie\u010diami asmenys, serantys \/ persirg\u0119 COVID-19 infekcija, bei asmenys, tur\u0117j\u0119 didel\u0117s rizikos s\u0105lyt\u012f su u\u017esikr\u0117tusiu COVID-19, ta\u010diau nesusirg\u0119 COVID-19 infekcija. Norin\u010dius dalyvauti raginami kreiptis tel. +37052752594 arba el. pa\u0161tu: covid19.lt@santa.lt.<\/p>\n

Kas yra biomedicininis tyrimas?<\/strong><\/p>\n

Biomedicininis tyrimas \u2013 tai medicinos moksl\u0173 hipotezi\u0173 patikrinimas mokslo tiriamaisiais metodais, kuriuo siekiama pl\u0117toti mokslo \u017einias apie \u017emogaus sveikat\u0105, ligas, j\u0173 diagnostik\u0105, gydym\u0105 ar profilaktik\u0105.<\/p>\n

Biomedicininio tyrimo metu \u017emogaus biologin\u0117 med\u017eiaga panaudojama ne paciento gydymui, profilaktikai ar slaugai, bet mokslinio tyrimo tikslais.<\/p>\n

Savanori\u0173 dalyvavimas biomedicininiame tyrime \u2013 tai j\u0173 \u012fna\u0161as \u012f mokslo pa\u017eang\u0105.<\/p>\n

COVID-19_LT tyrimo tikslas \u2013 gauti nauj\u0173 medicinos mokslo \u017eini\u0173, kurios ateityje pad\u0117t\u0173 gydyti SARS-CoV-2 viruso sukelt\u0105 COVID-19 infekcij\u0105 kitiems pacientams.<\/p>\n

Kas vyks, jei nuspr\u0119siu dalyvauti?<\/strong><\/p>\n

    \n
  • J\u016bs gal\u0117site dalyvauti tyrime, jei atitiksite \u0161iuos kriterijus:<\/li>\n
  • Buvote u\u017esikr\u0117t\u0119 SARS-CoV-2 virusu ir sirgote COVID-19 infekcija arba prasirgote besimptome ligos forma;<\/li>\n
  • Tur\u0117jote artim\u0105 s\u0105lyt\u012f su sergan\u010diaisiais COVID-19 infekcija;<\/li>\n
  • Pasira\u0161ysite informuoto asmens sutikimo form\u0105.<\/li>\n<\/ul>\n

    Kokie bus mano \u012fsipareigojimai?<\/strong><\/p>\n

    Atliekant \u0161\u012f tyrim\u0105 pakviesime Jus vien\u0105 kart\u0105 atvykti \u012f Vilniaus universiteto ligonin\u0117s Santaros klinik\u0173 Infekcini\u0173 lig\u0173 centr\u0105 (tel.: +3705 275 2594, Santari\u0161ki\u0173 g. 14, Vilnius) tyrimo proced\u016broms.<\/p>\n

    Tyrimo proced\u016bros<\/strong><\/p>\n

      \n
    • Informuoto asmens sutiko formos pasira\u0161ymas<\/li>\n
    • Klausimyno apie J\u016bs\u0173 sveikat\u0105 u\u017epildymas<\/li>\n
    • Keturi\u0173 kraujo m\u0117gintuv\u0117li\u0173 pa\u0117mimas i\u0161 venos. Vaikams 3 m\u0117gintuv\u0117liai.<\/li>\n
    • Visos \u0161ios proced\u016bros bendrai u\u017etruks ne daugiau nei 45-60 min.<\/li>\n<\/ul>\n

      Kas gali dalyvauti tyrime?<\/strong><\/p>\n

      Tinkate dalyvauti \u0161iame tyrime, jei atitinkate \u0161iuos kriterijus:<\/p>\n

        \n
      • esate nuo 0 iki 99 met\u0173;<\/li>\n
      • sirgote COVID-19 infekcija;<\/li>\n
      • buvote u\u017esikr\u0117t\u0119s SARS-CoV-2 virusu, bet nejutote joki\u0173 ligos simptom\u0173;<\/li>\n
      • tur\u0117jote artim\u0105 s\u0105lyt\u012f su sergan\u010diaisiais COVID-19 infekcija.<\/li>\n<\/ul>\n

        K\u0105 daryti, jei vis tiek turiu klausim\u0173?<\/strong><\/p>\n

          \n
        • Nedvejodami u\u017eduokite klausimus tyrimo gydytojui ar kitam tyrimo personalui.<\/li>\n
        • Tel.: +3705 275 2594<\/li>\n
        • covid19.lt@santa.lt<\/li>\n
        • ligita.jancoriene@santa.lt<\/li>\n
        • violeta.mikstiene@mf.vu.lt<\/li>\n
        • algirdas.utkus@mf.vu.lt<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"

          Lietuvos mokslininkai, tirdami COVID-19 liga sirgusi\u0173 ar s\u0105lyt\u012f su sergan\u010diaisiais tur\u0117jusi\u0173, ta\u010diau neu\u017esikr\u0117tusi\u0173 \u017emoni\u0173 genus, siekia nauj\u0173 \u017eini\u0173 apie koronavirus\u0105. Taip tikimasi nustatyti tuos genus, kurie apsaugo nuo COVID-19 infekcijos arba, prie\u0161ingai \u2013 lemia sunki\u0105 lig\u0105. Pla\u010diau apie tyrim\u0105 Vertinama, kad \u0161io tyrimo metu gauta informacija pad\u0117s sukurti veiksming\u0105 gydym\u0105, leis nusp\u0117ti, kokio sunkumo liga…<\/p>","protected":false},"author":5,"featured_media":20416,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-20415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-5jh","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/08\/45070_938ee2415fba7fc3e619f1f88ad20088.png","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/comments?post=20415"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20415\/revisions"}],"predecessor-version":[{"id":20417,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20415\/revisions\/20417"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media\/20416"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media?parent=20415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/categories?post=20415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/tags?post=20415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}